You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
N/A
SBC: Graphzepp Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: Ocular Transplantation LLC Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: TIGEN PHARMACEUTICALS Topic: N/AN/A
STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health -
Anatomy of the Central Nervous Sys.-A Multimedia Course
SBC: ORCCA TECHNOLOGY, INC. Topic: N/ADESCRIPTION (provided by applicant): This project will design, develop and evaluate an interactive multimedia program to provide integrated instruction about the embryology and anatomy of the adult human central nervous system. The program will also provide extensive self-testing for the competencies to be acquired through interaction with the software program. The ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Long Circulating Liposomal Camptothecins CAP and EAP
SBC: TIGEN PHARMACEUTICALS Topic: N/ADESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the further development of the highly lipophilic and blood-stable topoisomerase inhibitor, DB-67. In part, the pre-clinical and clinical evaluation of DB-67 is currently being supported by ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
Long Circulating Liposomal Camptothecins CAP and EAP
SBC: TIGEN PHARMACEUTICALS Topic: N/ADESCRIPTION (provided by applicant): Based on the extensive data generated during the phase I portion of our studies, there is sufficient and compelling information to support the further development of the highly lipophilic and blood-stable topoisomerase inhibitor, DB-67. In part, the pre-clinical and clinical evaluation of DB-67 is currently being supported by ...
STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health -
Potent Topoisomerase I Inhibition For Glioma Therapy
SBC: TIGEN PHARMACEUTICALS Topic: N/ADESCRIPTION (PROVIDED BY APPLICANT): DB-67 is a promising new silatecan (silylcamptothecin) analog that displays superior blood stability relative to the FDA-approved camptothecin congeners, topotecan and CPT- 11. DB-67 also exhibits a high degree of anti-cancer potency both in vitro and in vivo. DB-67 is a highly lipophilic camptothecin and active lactone levels pe ...
STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health -
ANYTIME, ANYPLACE LEARNING FOR CRITICAL CARE
SBC: ACADEMIC EDGE, INC. Topic: N/Acompletion, the entire course will provide a professional certificate with continuing nursing education contact hours or can be transferred as academic credit in an undergraduate-nursing program. The model for the OCPP to be developed in this project has three components: didactic core content, clinical practicum, and a Virtual Center of Best Practices. The core ...
STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
PRECISE 3D QCT TO MONITOR OSTEOPOROSIS THERAPY
SBC: IMAGE ANALYSIS, INC. Topic: N/ADESCRIPTION (provided by applicant):The growing number of women receiving drug treatment for osteoporosis underscores the need for sensitive methods to monitor therapy. Because it permits selective assessment of the trabecular and cortical bone, which may respond differently to disease and therapy, quantitative computed tomography (QCT) is well-suited to this purpose. However, the ability of QCT t ...
STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
PRECISE 3D QCT TO MONITOR OSTEOPOROSIS THERAPY
SBC: IMAGE ANALYSIS, INC. Topic: N/ADESCRIPTION (provided by applicant):The growing number of women receiving drug treatment for osteoporosis underscores the need for sensitive methods to monitor therapy. Because it permits selective assessment of the trabecular and cortical bone, which may respond differently to disease and therapy, quantitative computed tomography (QCT) is well-suited to this purpose. However, the ability of QCT t ...
STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
